Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Elias Chalouhi El Khouri"'
Autor:
Mark C. Genovese, Josephine Glover, Maria Greenwald, Wieslawa Porawska, Elias Chalouhi El Khouri, Eva Dokoupilova, Juan Ignacio Vargas, Mykola Stanislavchuk, Herbert Kellner, Elena Baranova, Nobuhito Matsunaga, Rieke Alten
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-12 (2019)
Abstract Objective To compare the efficacy, serum drug concentrations, immunogenicity, and safety of FKB327 with the adalimumab reference product (RP) in combination with methotrexate in patients with moderate-to-severe, active rheumatoid arthritis (
Externí odkaz:
https://doaj.org/article/1252aed2b70243f88faf1f3693138e6a
Autor:
Vyacheslav Zhdan, Sunghyun Kim, Rene Westhovens, Jee Hye Suh, Piotr Wiland, Janusz Jaworski, Seul Gi Lee, Marek Zawadzki, Pavel Shesternya, Roman Yatsyshyn, Delina Ivanova, Sergii Shevchuk, Paweł Hrycaj, Elias Chalouhi El-Khouri, Mykola Stanislavchuk, Éva Balázs, Alfredo Berrocal Kasay, Larisa Eliseeva, Dae Hyun Yoo, Sang Joon Lee, Noo Ri Han, Jakub Trefler
Publikováno v:
Rheumatology (Oxford, England)
Objective To assess non-inferiority of s.c. to i.v. CT-P13 in RA. Methods Patients with active RA and inadequate response to MTX participated in this phase I/III double-blind study at 76 sites. Patients received CT-P13 i.v. 3 mg/kg [week (W) 0 and W2
Autor:
Sang Joon Lee, Fedra Irazoque-Palazuelos, Olena Garmish, Pavel Shesternya, Won Park, Ljubinka Božić-Majstorović, Alfredo Berrocal Kasay, Sławomir Jeka, Sung Young Lee, Paweł Hrycaj, Francisco G. Medina-Rodriguez, Natalia Fomina, Dae Hyun Yoo, Elias Chalouhi El-Khouri, Francisco Fidencio Cons Molina, Pedro Miranda, Yun Ju Bae, Seung Cheol Shim, Chang-Hee Suh, Piotr Wiland, Jose Chavez-Corrales
Publikováno v:
Rheumatology (Oxford, England)
Objective To evaluate the efficacy and safety of CT-P10, a rituximab biosimilar after a single switch, during a multinational, randomized, double-blind Phase 3 trial involving patients with RA. Methods Patients received 48 weeks’ treatment with CT-
Autor:
Dmytro Rekalov, Piotr Wiland, Sławomir Jeka, Sung Young Lee, Pavel Shesternya, Olena Piura, Francisco G. Medina-Rodriguez, Mauricio Abello-Banfi, Natalia Fomina, Dragana Milakovic, Andreas Krause, Seung Cheol Shim, Paweł Hrycaj, Dae Hyun Yoo, Chang-Hee Suh, Alfredo Berrocal Kasay, Thomas Linde, Sung Hwan Kim, Fedra Irazoque-Palazuelos, Elias Chalouhi El-Khouri, Olena Garmish, Francisco Fidencio Cons Molina, Won Park, Sang Joon Lee, Jose Chavez-Corrales, Pedro Miranda, Ljubinka Božić-Majstorović
Publikováno v:
mAbs. 10(6)
This multinational, randomized, double-blind trial, (ClinicalTrials.gov identifier NCT02149121) was designed to demonstrate equivalence in pharmacokinetics and efficacy between CT-P10 and innovator rituximab (RTX) in patients with rheumatoid arthriti